Category: Infectious Diseases
Global Infectious Diseases
-
2023 Certain Infectious and Parasitic Diseases Global Market Size & Growth Report with Global Recession Risk Impact
... growth, and share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 216 countries. Figures are from 2014 through 2022, with forecasts for 2023 and 2027. The ... Read More
-
Emerging Infectious Disease Diagnostics Market - A Global and Regional Analysis: Focus on Application, Technology, Type of Infection, Disease Type, End User, and Country Analysis - Analysis and Forecast, 2023-2033
... The global emerging infectious disease diagnostics market was valued at $19.56 billion in 2022 and is expected to reach $37.21 billion by 2033, growing at a CAGR of 6.19% between 2023 and 2033. The key ... Read More
-
Humanized Mouse and Rat Model Market by Type (Genetic Models, Cell-based Models (CD34, BLT, PMC), Rat Models), Application (Oncology, Immunology, Neuroscience, Toxicology, Infectious Diseases), End User (Pharma, Biotech) & Region - Global Forecast to 2028
... The global humanized mouse and rat model market is projected to reach USD 349 million by 2028 from USD 259 million in 2023, at a CAGR of 6.2% during the forecast period of 2023 to ... Read More
-
Medical Countermeasures Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... global medical countermeasures market is experiencing a major breakthrough in the healthcare industry, driven by the increasing demand for accessible and effective medicines to combat uncertain outbreaks. With the need for robust and apt medical ... Read More
-
2023 Global: Infection Surveillance Solutions Market - Innovative Markets Forecast (2029) report
... the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 ... Read More
-
Immunodiagnostics Market Forecast to 2030 - Global Analysis by Product [Enzyme-Linked Immunosorbent Assays (ELISA), Chemiluminescence Immunoassays (CLIA), Radioimmunoassays (RIA), and Others], Clinical Indication (Infectious Diseases, Hepatitis+HIV, Endocrinology, Gastrointestinal, Metabolics, and Others), End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others), and Geography
... Diagnostic Laboratories, Academic & Research Institutes, and Others), and Geography The immunodiagnostics market size is expected to reach US$ 34,487.80 million by 2030 from US$ 19,218.89 million in 2022; it is estimated to record a ... Read More
-
Cell and Gene Therapy Bioassay Services Market by Type of Therapy (Cell Therapy and Gene Therapy), Therapeutic Area (Oncological Disorders, Infectious Diseases, Autoimmune Disorders, Rare / Genetic Disorders, Cardiovascular Disorders, Metabolic Disorders, Blood Disorders, Neurological Disorders, Ophthalmic Disorders and Other Therapeutic Areas), Scale of Operation (Discovery, Preclinical and Clinical) and Geography (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World): Industry Trends and Global Forecasts, 2021-2030
... Disorders, Ophthalmic Disorders and Other Therapeutic Areas), Scale of Operation (Discovery, Preclinical and Clinical) and Geography (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World): Industry Trends and Global Forecasts, 2021-2030 Given ... Read More
-
Site Management Organizations Market by Therapeutic Areas (Oncological Disorders, CNS Disorders, Infectious Diseases, Cardiovascular Diseases and Others), Trial Phase (Phase I, Phase II, Phase III and Phase IV), Clinical Trial Components (Site Management, Onsite Monitoring, Project Management and Others), Type of Interventions (Therapeutics, Devices and Surgical Procedure) and Key Geographies (North America, Europe, Asia-Pacific, Latin America, MENA, and RoW): Industry Trends and Global Forecasts, 2021-2035
... Project Management and Others), Type of Interventions (Therapeutics, Devices and Surgical Procedure) and Key Geographies (North America, Europe, Asia-Pacific, Latin America, MENA, and RoW): Industry Trends and Global Forecasts, 2021-2035 Clinical trials form an integral ... Read More
-
2023 Global Forecast for Pneumococcal Vaccines Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2024 ... Read More
-
Global Clinical Risk Grouping Solutions Market - 2023-2030
... million by 2030. The market is exhibiting at a CAGR of 13.9% during the forecast period (2023-2030). Risk management in healthcare is a complex set of systems, processes, procedures, and reporting structures designed to detect, ... Read More
-
Viral Vector Production Market By Viral Vector Type (Adenoviral Vectors, Lentiviral Vectors, Retroviral Vectors, Adeno-Associated Viral Vectors, Other Viral Vectors), By Indication (Cancer, Genetic Disorders, Infectious Diseases, Other Diseases), By Application (Gene Therapy, Vaccinology): Global Opportunity Analysis and Industry Forecast, 2023-2032
... Opportunity Analysis and Industry Forecast, 2023-2032 The viral vector production market was valued for $1.1 billion in 2022 and is estimated to reach $6.1 billion by 2032, exhibiting a CAGR of 18.8% from 2023 to ... Read More
-
Generic Drugs Market By Therapeutic Application (Cardiovascular, Infectious Diseases, Cancer, Diabetes, Others), By Route of Administration (Oral, Injections, Others), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online providers): Global Opportunity Analysis and Industry Forecast, 2023-2032
... The Generic Drugs Market was valued for $385,320.00 million in 2022 and is estimated to reach $835,706.50 million by 2032, exhibiting a CAGR of 8.1% from 2023 to 2032. Generic drugs is a medication similar ... Read More
-
Global Nanomedicine Market Assessment, By Nanomolecule Type [Nanoparticles (Polymer-Based, Lipid-Based, Nanocrystals, Inorganic, others), Nanoshells, Nanodevices, Nanotubes], By Application [Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others], By Disease Indication [Oncological Diseases, Infectious Diseases, Orthopaedic Diseases, Cardiovascular Diseases, Others], By Region, Opportunities, and Forecast 2016-2030F
... Cardiovascular Diseases, Others], By Region, Opportunities, and Forecast 2016-2030F Global Nanomedicine Market size was valued at USD 168.4 billion in 2022 which is expected to reach USD 319.72 billion in 2030 growing with a CAGR ... Read More
-
Nanotechnology Drug Delivery Market By Formulation (Lipid-based nanomedicine, Polymer-based nanomedicine, Nanocrystals, Others), By Application (Oncology and Hematology, Infectious diseases, Orthopedics, Neurology, Urology, Immunology, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
... market was valued for $87.5 billion in 2022 and is estimated to reach $209.5 billion by 2032, exhibiting a CAGR of 9.1% from 2023 to 2032. Nanotechnology is a scientific field that involves manipulating matter ... Read More
-
Global Generic Pharmaceuticals Market Size study & Forecast, by Type ( Simple Generics, Specialty Generics, Biosimilars), by Application ( Central Nervous System Disorders, Respiratory Diseases, Hormones & Related Diseases, Gastrointestinal Diseases, Cardiovascular Diseases, Infectious Diseases and Others), by Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable and Others), by Distribution Channel (Online Pharmacies, Hospitals Pharmacies, Retail Pharmacies)and Regional Analysis, 2023-2030
... and Others), by Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable and Others), by Distribution Channel (Online Pharmacies, Hospitals Pharmacies, Retail Pharmacies)and Regional Analysis, 2023-2030 Global Generic Pharmaceuticals Market is valued ... Read More
-
2023 Global Forecast for Infection Surveillance Solutions Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Computer Systems Design Services industry. The product or service category is within the NAICS Computer Systems Design Services industry. The global market is expected to ... Read More
-
Global Infection Surveillance Solutions Market Size, Share & Industry Trends Analysis Report By Product & Services (Software (On-premise and Web-based Software) and Services), By End User, By Regional Outlook and Forecast, 2023 - 2029
... Global Infection Surveillance Solutions Market size is expected to reach $1.3 billion by 2029, rising at a market growth of 12.9% CAGR during the forecast period. The goal of infection surveillance solutions is to accurately ... Read More
-
Next Generation Sequencing Market - By Product (Instruments, Consumables, Services), By Application (Research, Clinical {Cardiovascular, Reproductive Health, Cancer, Infectious Diseases}), By Type (Whole Genome Sequencing, Exome Sequencing, Targeted Sequencing), By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing), By End-use (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies) & Forecast, 2023 - 2032
... Semiconductor Sequencing), By End-use (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies) & Forecast, 2023 - 2032 Next-generation sequencing (NGS) market is set to witness substantial growth through 2032 owing to the increasing use of the ... Read More
-
In Vitro Diagnostic Market by Product Type (Reagents, Instruments, and Software & Services), Technique (Immunodiagnostics, Hematology, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Other IVD Techniques), Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Other Indications), and End-User Industry (Standalone Laboratories, Hospitals, Academics & Medical Schools, Point Of Care Testing, and Others) – Global Opportunity Analysis and Industry Forecast 2023–2030
... Nephrological Diseases, Gastrointestinal Diseases, and Other Indications), and End-User Industry (Standalone Laboratories, Hospitals, Academics & Medical Schools, Point Of Care Testing, and Others) – Global Opportunity Analysis and Industry Forecast 2023–2030 The In Vitro Diagnostic ... Read More
-
Global Rare Diseases Treatment Market Size study & Forecast, by Therapeutic Area (Cancer, Neurological Conditions, Cardiovascular Conditions, Musculoskeletal Conditions, Hematologic Disorders, Infectious Diseases, Metabolic disorders, Endocrine disorders, Others) by Route of Administration (Oral, Injectable, Others), by Drug Type (Biologics, Biosimilar, Small Molecule), by Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy) and Regional Analysis, 2022-2029
... by Drug Type (Biologics, Biosimilar, Small Molecule), by Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy) and Regional Analysis, 2022-2029 Global Rare Diseases Treatment Market is valued at approximately USD 119.6 billion in 2021 and ... Read More
-
Global Gene Therapy Market Size study & Forecast, by Vector [Viral VectorsNon-viral VectorsBy Delivery Method (In Vivo, Ex Vivo) by Application (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Others), By Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Receptors, Others), and Regional Analysis, 2022-2029
... (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Receptors, Others), and Regional Analysis, 2022-2029 Global Gene Therapy Market is valued at approximately USD 6.2 billion in 2021 and is anticipated to grow with a healthy growth rate ... Read More
-
Global Women’s Health Technology Market Size study & Forecast, by Technology type (Surgical, Diagnostic, Contraceptive, Labor & Delivery, Critical Care), By Indication (Cancer, Infertility, Menstruation, Pregnancy, Post-menopausal Syndrome, Pelvic Disorders, Infectious Diseases), By End Users (Hospitals, Obstetrics & Gynaecology Clinics, Diagnostics Laboratory, Ambulatory Surgery Centers (ASC)), and Regional Analysis, 2022-2029
... (Hospitals, Obstetrics & Gynaecology Clinics, Diagnostics Laboratory, Ambulatory Surgery Centers (ASC)), and Regional Analysis, 2022-2029 Global Women’s Health Technology Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with ... Read More
-
Antimicrobial Susceptibility Testing Market by Product (Manual, Automated), Type (Antibacterial, Antifungal), Application (Clinical Diagnostics), Method (ETEST, Disk Diffusion, Agar Diffusion, Genotyping), End User & Region - Global Forecasts to 2027
... is projected to reach USD 4.7 billion by 2027 from USD 3.6 billion in 2022, at a CAGR of 5.5% during the forecast period. The significant growth of the antimicrobial susceptibility testing market is largely ... Read More
-
Infection Surveillance Solutions Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Offering (Software, Services); By Infection Type (Surgical Site Infections (SSI), Blood Stream Infections (BSI), Urinary Tract Infections (UTI)); By End Use (Long Term Care Facilities, Hospitals); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
... By End Use (Long Term Care Facilities, Hospitals); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) Global Infection Surveillance Solutions Market Size More Than Doubles to Touch USD 1.2 Billion ... Read More
-
Companion Diagnostics Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Product & Service (Assays, Kits & Reagents, Software & Services); By Technology (Polymerase Chain Reaction, Next-generation Sequencing, In-Situ Hybridization, Immunohistochemistry); By Indication (Cancer, Neurological Disorders, Cardiovascular Diseases, Infectious Diseases); By End User (Pharmaceutical & Biopharmaceutical, Reference Laboratories, Contract Research Organizations); By Region (North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA))
... Immunohistochemistry); By Indication (Cancer, Neurological Disorders, Cardiovascular Diseases, Infectious Diseases); By End User (Pharmaceutical & Biopharmaceutical, Reference Laboratories, Contract Research Organizations); By Region (North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa ... Read More